<p>Listen to Ashley Knapp, registered nurse, co-founder of Local Infusion and a seasoned leader in the infusion therapy space, share her experience about practical considerations for the application disease-modifying therapies for T1D in the community, with a specific focus on how community infusion centers or clinics can think about starting or establishing a clinical infusion program with teplizumab.</p>

Listen to Ashley Knapp, registered nurse, co-founder of Local Infusion and a seasoned leader in the infusion therapy space, share her experience about practical considerations for the application disease-modifying therapies for T1D in the community, with a specific focus on how community infusion centers or clinics can think about starting or establishing a clinical infusion program with teplizumab.

Teplizumab infusions in the real-world

The DETECT T1D initiative is aiming to provide clinicians and patients with information on the screening and early detection of T1D, as well as therapeutic advances to delay disease progression. The development of therapies to delay progression to clinical T1D has the potential to alter paradigms of care, and with it there is an emphasis on screening, early detection, multidisciplinary care, and patient education to help bring these advances to practice.

Share Teplizumab infusions in the real-world

Sign up to save your podcasts

Teplizumab infusions in the real-world

Teplizumab infusions in the real-world